Innovation

Inside the Bungled FDA Approval of a Once-Hyped ALS Drug

THINK TWICE

Depending on who you talk to, Relyvrio is either a game-changing treatment, or a cautionary tale against putting the proverbial cart before the horse.

Niamh Rowe
Niamh Rowe
221122-rowe-als-fda-hero_kxba26
Photo Illustration by Erin O'Flynn/The Daily Beast/Getty
Niamh Rowe

Niamh Rowe

niamhrowe7

Got a tip? Send it to The Daily Beast here.

Trending Now
PoliticsSteve Bannon Ramps Up MAGA Civil War With Graphic Threat to Elon Musk
Amethyst Martinez
PoliticsElon Musk Assumes New X Identity Linked to White Supremacists
Janna Brancolini
U.S. NewsSlapped-Down Musk Forced Into Massive U-Turn After MAGA Meltdown
Leigh Kimmins
PoliticsRepublicans Admit MAGA Civil War Is a Total ‘S**tshow’—and It’s Only Gonna Get Worse
Nico Hines
PoliticsTrump Ticks Off MAGA With U-Turn on Jimmy Carter
Amethyst Martinez